5th Jul 2021 11:15
FORM 8.3
Amendment to Purchase & Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 01 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
8,472,253 | 3.36% | 411,805 | 0.16% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
330,516 | 0.13% | 6,582,967 | 2.61% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
8,802,769 | 3.49% | 6,994,772 | 2.78% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 275 | 10.7100 GBP |
| Purchase | 674 | 10.6979 GBP |
| Purchase | 851 | 10.6989 GBP |
| Purchase | 1,067 | 10.6994 GBP |
| Purchase | 2,024 | 10.6900 GBP |
| Purchase | 8,906 | 10.6984 GBP |
| Purchase | 14,635 | 10.6873 GBP |
| Purchase | 23,200 | 10.6880 GBP |
| Purchase | 29,820 | 10.6800 GBP |
| Purchase | 30,775 | 10.6869 GBP |
| Purchase | 70,710 | 10.6897 GBP |
| Purchase | 96,101 | 10.6844 GBP |
| Purchase | 152,278 | 10.7000 GBP |
| Purchase | 400,000 | 10.6753 GBP |
| Purchase | 500,000 | 10.6950 GBP |
| Purchase | 1,000,000 | 10.6980 GBP |
| Sale | 420 | 10.6950 GBP |
| Sale | 4,044 | 10.6850 GBP |
| Sale | 6,944 | 10.6861 GBP |
| Sale | 10,347 | 10.6910 GBP |
| Sale | 10,971 | 10.6886 GBP |
| Sale | 17,754 | 10.6949 GBP |
| Sale | 24,296 | 10.6836 GBP |
| Sale | 69,851 | 10.7003 GBP |
| Sale | 92,536 | 10.7000 GBP |
| Sale | 133,824 | 10.6929 GBP |
| Sale | 143,914 | 10.6799 GBP |
| Sale | 500,000 | 10.6914 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | ||
| SWAP | Long | 300 | 10.6799 GBP |
| CFD | Long | 4,044 | 10.6850 GBP |
| CFD | Long | 20,476 | 10.6892 GBP |
| SWAP | Long | 24,798 | 10.6840 GBP |
| SWAP | Long | 27,689 | 10.6909 GBP |
| SWAP | Long | 43,961 | 10.6817 GBP |
| SWAP | Long | 74,795 | 10.7000 GBP |
| SWAP | Short | 128 | 10.7100 GBP |
| SWAP | Short | 268 | 10.6950 GBP |
| SWAP | Short | 286 | 10.6924 GBP |
| SWAP | Short | 1,587 | 10.6921 GBP |
| SWAP | Short | 36,819 | 10.7051 GBP |
| SWAP | Short | 74,795 | 10.7000 GBP |
| SWAP | Short | 1,400,000 | 10.6915 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 5 Jul 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210705005086/en/
Copyright Business Wire 2021
Related Shares:
BarclaysUDG.L